Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03199586
Title Phase 1 Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Solid Tumors (Including Lymphoma)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novita Pharmaceuticals, Inc.
Indications

lymphoma

ovarian cancer

liver cancer

pancreatic cancer

esophageal cancer

lung cancer

breast cancer

colon cancer

prostate cancer

Therapies

NP-G2-044

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.